Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

Pfizer To Quit GSK's Consumer Health JV Following Its Spin-Off

Pfizer Inc. (NYSE:PFE) intends to sell its 32% investment in Haleon, a consumer health joint venture with GSK plc (NYSE:GSK), after the business is spun out as an independent listed company in July, reported Reuters. Pfizer had previously indicated that it might seek to sell its stake in Haleon, a consumer health company and…

Benzinga

U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients

Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time.

Reuters

Man died of 'catastrophic' Covid jab reaction after outdated advice from vaccine hub

Jack Hurn became unwell with "castatrophic" blood clots eight days after receiving the AstraZeneca vaccine despite having been reassured by staff that it would be safe for him

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

Planning a holiday? What’s the COVID situation in Bali, Fiji, NZ and the UK?

Here are a few general tips for a safer and enjoyable holiday, and a quick look at the COVID situation in four popular holiday destinations.

The New Daily

Planning a holiday? What's the COVID situation in Bali, Fiji, NZ and the UK?

Many of us are considering a long-delayed overseas trip. However, despite what our politicians are telling us, the pandemic is not over yet, and there is always the risk you could catch COVID on holiday or just before you depart.

The Conversation

Spain's Covid booster jab entry requirement for all holidaymakers explained

Tourists going to Spain might need to prepare a more thorough proof of vaccination.

Daily Record

Read news from The Economist, FT, and more,
with one subscription

Pfizer's Combo Therapy For Fatty Liver Disease Gets FDA Fast Track Status

The U.S. Food and Drug Administration has granted Fast Track designation to Pfizer’s (NYSE: PFE) Ervogastat/Clesacostat Combination therapy for the treatment of Non-Alcoholic Steatohepatitis (NASH).

Benzinga

The Daily Biotech Pulse: Setback For NRx Pharma's COVID Study, Fast Track Tag For Pfizer's NASH Combo Therapy, Reata's Ataxia Drug In FDA Review

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

How important is the COVID-19 booster shot for 5-to-11-year-olds? 5 questions answered

COVID-19 case numbers are rising again in the U.S. – including among children. In mid-May 2022, the Food and Drug Administration authorized a booster shot of the COVID-19 vaccine for U.S. children ages 5 to 11, and the Centers for Disease Control and Prevention followed by recommending a booster shot…

The Conversation

Pfizer Offers to Sell Medicines at Cost to Poorest Countries

US pharmaceutical giant Pfizer on Wednesday said it would sell its patented drugs on a not-for-profit basis to the world's poorest countries, as part of a new initiative announced at the World Economic Forum in Davos. "The time is now to begin closing this gap" between people with access to…

Asharq Al-Awsat

Health brands' reputation rise after pandemic

A renewed focus on health and wellness has been a boon to the reputations of health care companies, according to new rankings from the annual Axios/Harris Poll 100.

Axios

Morning Brief: Top Financial Stories Dominating on Wednesday, May 25

Reuters Ford To Pay $19.2M In Multi-State Settlement For False Advertising Claims

Benzinga

Pfizer To Sell 23 Patented Drugs, Vaccines At Lower Prices To Poorer Countries

Pfizer Inc (NYSE:PFE) will sell over 20 patent-protected drugs and vaccines at not-for-profit prices to 45 of the world's poorest countries. Under the program, Pfizer will begin shipping the medicines first to Ghana, Malawi, Rwanda, Senegal, and Uganda before the end of this year, Chief Executive Albert Bourla said in an interview. This will…

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Pfizer to offer all its drugs not-for-profit to 45 lower-income countries

Company launches ‘healthier world’ accord in Davos and speaks to other pharma firms about similar steps

The Independent UK

Davos updates | Pfizer offers low-cost drugs to poor nations

Pfizer says it will provide nearly two dozen products, including its top-selling COVID-19 vaccine and treatment, at not-for-profit prices in some of the world’s poorest countries

Bangkok Post

Cambodia, Laos to benefit as Pfizer slashes drug prices for poorest nations

Pfizer Inc plans to sell its entire portfolio of brand-name drugs at cost in as many as 45 lower-income countries, including Cambodia and Laos, one of the most comprehensive and ambitious drug-access programmes ever announced by a large pharmaceutical manufacturer.

Reuters

Pfizer to sell all its patented drugs at nonprofit price in low-income countries

Pfizer Inc will make all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not-for-profit price to 45 of the world's poorest countries, the drugmaker said on Wednesday.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Pfizer to offer low-cost medicines, vaccines to poor nations

Pfizer says it will provide nearly two dozen products at not-for-profit prices in some of the world’s poorest countries

Reuters

Germany's vaccine panel says one COVID shot enough for children

Germany's vaccine advisory panel on Tuesday said one COVID-19 shot was enough for healthy five- to 11-year-olds because most of them had already undergone an infection, maintaining its cautious approach.

Benzinga

Pfizer's Ulcerative Colitis Candidate Shows Remission In Over 30% Of Patients In Pivotal Studies

Pfizer Inc (NYSE:PFE) has announced detailed results from two pivotal studies from ELEVATE UC Phase 3 program evaluating etrasimod for active ulcerative colitis (UC). The drug, etrasimod, was Pfizer's key asset in its $6.7 billion deal for Arena Pharmaceuticals last year. UC is an inflammatory bowel disease that affects around 3.8 million people in North…

Wales Online

What happened to the AstraZeneca vaccine? How blood clot scares tarnished its reputation

While the AZ./Oxford vaccine has all but vanished from richer countries, it has continued to be rolled out elsewhere

The Independent UK

China's bet on homegrown mRNA vaccines holds back nation

China is trying to navigate its biggest coronavirus outbreak without a tool it could have adopted many months ago, the kind of vaccines that have proven to offer the best protection against the worst outcomes from COVID-19

The Hindu

Morning Digest | Quad leaders meet in Tokyo at 2nd in-person summit; India to be the leader of green hydrogen, says Puri in Davos, and more

A select list of stories to read before you start your day

The Independent UK

What's next for COVID-19 vaccines for youngest US children

Parents hoping to get their youngest children vaccinated against COVID-19 have some encouraging news

1 … 48 49 50 51

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.